Pragma Bio

?? Join us tomorrow (Nov 19th) at 10:30 am PST/ 1:30 pm EST, for the DealForma webinar, where our CBO, Orly Levitan, will share insights on Pragma Bio's innovation, deal-making strategies, and perspectives on the biotech ecosystem. Don't miss this opportunity to hear from Orly and Chris Dokomajilar in what promises to be a short, fantastic, and insightful session. ?? ?? Register HERE: https://hubs.ly/Q02YBkmN0

??Pragma Bio's new article, “PIKASO & Artificial Intelligence: Pushing the Boundaries of Traditional Drug Discovery”, is out!!! ?????? In this follow-up to our previous articles introducing the concept of BGC-focused discovery, and PIKASO - our innovative small molecule discovery platform, we dive into how AI is transforming each stage of our drug discovery process. ?? By thoughtfully integrating AI into every step, PIKASO leverages our unique proprietary database, cutting-edge computational pipeline, and synthetic biology and pharmacology expertise to generate breakthrough drug candidates with greater precision, speed, and efficiency. ?? ?? With PIKASO, Pragma Bio is turning what was once a serendipitous and risk-laden process into a targeted and streamlined one, significantly reducing timelines and improving the likelihood of success in discovering and developing novel drug candidates. ? ?? ?? #biotech #Innovation #BGC #SyntheticBiology #SynBio #AI #AIML #SmallMolecules #microbiology #Microbiome #DrugDiscovery #TechBio #bioconvergence

Thrilled to be speaking at BioVenture Nexus 2024 on October 3-4 at the JW Marriott - The Ritz Carlton, Los Angeles! ?? This is?the?event for anyone serious about Biotech, Synthetic Biology, AI in bio, Life sciences, Food Tech, AgriTech, Climate Tech, and beyond. Can't wait to share insights and connect with top innovators, VCs, and decision-makers! Join us!??https://lnkd.in/gFn2x6gc

?? Introducing PIKASO: Translating Microbiology into Actionable Chemistry ?? At Pragma Bio, we are pushing the boundaries of small molecule discovery with our platform, PIKASO = Pragma Insights, Knowledge, And Scientific Outcomes. Inspired by Picasso’s journey of simplifying complexity, we have developed a revolutionary approach that distills the complexity of microbial biosynthetic gene clusters (BGCs) into a streamlined engine for discovering bioactive molecules. ?? How does it work? ---------------------- 1?? Core Foundation – We mine biologically and clinically relevant BGCs from nature, focusing on microbial ecosystems to identify potent small molecules. 2?? Leverage Evolution – These molecules, honed by evolution, offer us a significant head start in drug discovery. 3?? Artistry in Science – Using our integrated platform, we optimize and refine these natural products for maximal therapeutic potential. Our unique approach, inspired by Picasso’s art, strips away the complexity to focus on the core elements, enabling us to accelerate drug discovery for human and animal health, as well as provide crop solutions, and support development of strain-based products . ?? ?? Like Picasso with the bull, we turn complexity into clarity, with each discovery building on the last. ?? ???? #biotech #Innovation #BGC #SyntheticBiology #SynBio #AI #AIML #SmallMolecules #microbiology #emr #ehr #Microbiome #DrugDiscovery #TechBio

We are incredibly grateful to our partners at Emerald Cloud Lab. Their platform has been a game-changer for us at Pragma Bio, enabling us to achieve unprecedented throughput and productivity. The ability to run over 1,200 samples with sustained quality in such a short time is truly remarkable. Special thanks to Pragma Bio team members, Peter McCaffrey, MD, FCAP, Caitlyn B., and Jesus F. Barajas, Ph.D. on working diligently with the exceptional team at ECL. This is a perfect example of what can be done when two partners align on a vision and work side-by-side to make it a reality. For anyone interested in how to build a scalable biotech in a cost-effective manner, this is a must-read. Read Here: https://lnkd.in/gxQiGCRg #cloudlab #cloudlabboost #biotechnology #startups #emeraldcloudlab

Orly Levitan, Pragma Bio's VP of Partnerships and Business Development will be attending #BIO2024 in just a week. ?? ??? Pragma Bio is using Biosynthetic Gene Clusters (BGCs) to reinvent small molecules discovery. ?? If you'd like to hear more on how we partner and use data + AI/ML + SynBio to find, make, and test BGCs-based small molecules - Click bellow to set up a meeting with Orly in San Diego. #BIO2024 #conference #innovation #partnership #biotech #techbio #pharma #smallmolecules #ai #aiml #synbio

Exciting News from Pragma Bio!??? We're thrilled to announce the addition of three esteemed individuals to our leadership team: Stuart Chaffee, PhD, as Independent Board Member, and Raquel Izumi, PhD, and Abbas Kazimi, M.S., as Strategic Advisors. Join us in welcoming Stuart, Raquel, and Abbas to the Pragma Bio family as we continue to push the boundaries of biotechnology and transform healthcare.??? https://lnkd.in/ezn5-9Re #Biotechnology #Leadership #Innovation #Healthcare #AI #SynBIO #pharma #business #businessdevelopment #BiotechNews #PragmaBio #biotech #techbio #smallmolecules

?? Pragma Bio is excited to share our latest article "Decoding BGCs: Nature's Blueprint for Tomorrow's Medicines". Ever wondered what are Biosynthetic Gene Clusters (BGCs) and what is their role in medicine? ?? ?? ?? Dive into our blog post to explore how these clusters unlock nature's pharmacy, offering potential for groundbreaking drug discovery and far beyond. Join us at Pragma Bio as we navigate BGC exploration for a a better and healthier planet. ?? ?? ?? #inovation #biotech #BGC #Medicine #DrugDiscovery #biotech #techbio #microbiome #microbiology #syntheticbiology #ai #aiml #smallmolecules

This is starting tomorrow! ?? ?? ?? Kareem Barghouti our CEO is in Dubai and participating at EMERGE 2050 - Tomorrow, Wednesday (May 8th, 4pm) he'll be participating in Ethics of Ai in healthcare panel: "AI as the backbone of Precision Medicine and how regulations can keep up with the ever-changing technology" ?? ?? - And.... Thursday 10 am he'll be presenting Pragma Bio, our vision, mission, approach and #PICASSO platform. ?? ?? Be there is you can! #PISCASS #innovation #startup #conference #smallmolecules #microbiome #biotech #techbio #investmetns